Blinatumomab provoked fatal heart failure.
Darvishi B, Farahmand L, Jalili N, Majidzadeh-A K.
Darvishi B, et al.
Int Immunopharmacol. 2016 Dec;41:42-46. doi: 10.1016/j.intimp.2016.10.017. Epub 2016 Oct 28.
Int Immunopharmacol. 2016.
PMID: 27816725
Review.
Mentioned in Blinatumomab (Blincyto ) clinical safety report, a 5 year old boy with acute lymphoblastic leukemia (ALL) receiving Blincyto with the concentration of 30mug/m(2)/day on the fourth day of therapy developed both Cytokine Release Syndrome (CRS) and Tumor Lysis S …
Mentioned in Blinatumomab (Blincyto ) clinical safety report, a 5 year old boy with acute lymphoblastic leukemia (ALL) receiving Blincyto w …